Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
154.42
Dollar change
-0.98
Percentage change
-0.63
%
IndexDJIA, S&P 500 P/E29.47 EPS (ttm)5.24 Insider Own0.17% Shs Outstand2.61B Perf Week-2.50%
Market Cap371.73B Forward P/E14.37 EPS next Y10.75 Insider Trans-1.14% Shs Float2.40B Perf Month2.71%
Income13.64B PEG5.67 EPS next Q2.37 Inst Own70.79% Short Float / Ratio0.55% / 1.95 Perf Quarter-5.07%
Sales95.35B P/S3.90 EPS this Y-1.31% Inst Trans-0.39% Short Interest13.19M Perf Half Y-3.49%
Book/sh29.59 P/B5.22 EPS next Y7.28% ROA7.56% Target Price175.84 Perf Year-12.84%
Cash/sh9.77 P/C15.81 EPS next 5Y5.20% ROE17.70% 52W Range144.95 - 181.04 Perf YTD-12.58%
Dividend4.60 P/FCF23.62 EPS past 5Y70.31% ROI14.02% 52W High-14.70% Beta0.53
Dividend %2.98% Quick Ratio0.96 Sales past 5Y4.55% Gross Margin68.02% 52W Low6.53% ATR2.06
Employees152700 Current Ratio1.21 Sales Q/Q-10.36% Oper. Margin26.68% RSI (14)53.41 Volatility1.26% 1.32%
OptionableYes Debt/Eq0.42 EPS Q/Q18.10% Profit Margin14.31% Rel Volume0.91 Prev Close155.40
ShortableYes LT Debt/Eq0.37 EarningsOct 17 BMO Payout66.07% Avg Volume6.78M Price154.42
Recom2.17 SMA201.58% SMA501.07% SMA200-3.10% Volume6,146,037 Change-0.63%
Date Action Analyst Rating Change Price Target Change
Dec-01-23Upgrade UBS Neutral → Buy $167 → $180
Oct-05-23Initiated RBC Capital Mkts Outperform $178
Sep-06-23Initiated HSBC Securities Hold $175
May-30-23Resumed Citigroup Buy $185
Mar-29-23Initiated UBS Neutral $164
Mar-01-23Initiated Guggenheim Neutral $161
Nov-18-22Initiated Credit Suisse Neutral $170
Oct-18-22Initiated Barclays Equal Weight $175
Oct-14-22Reiterated BofA Securities Neutral $185 → $178
Jun-22-22Initiated Daiwa Securities Outperform
Today 01:05PM
11:35AM
Dec-09-23 05:51AM
Dec-07-23 04:15PM
12:47PM
11:50AM Loading…
11:50AM
11:20AM
08:52AM
Dec-06-23 12:35PM
11:29AM
09:19AM
08:58AM
06:59AM
05:55AM
01:21AM
06:23PM Loading…
Dec-05-23 06:23PM
05:45PM
12:03PM
11:12AM
08:07AM
07:57AM
07:40AM
07:18AM
07:17AM
07:15AM
06:01AM
Dec-04-23 05:30AM
Dec-03-23 08:00AM
08:00AM
07:00AM
05:30AM Loading…
05:30AM
Dec-02-23 02:05PM
06:14AM
Dec-01-23 12:33PM
09:32AM
Nov-30-23 05:16PM
04:30PM
11:04AM
08:40AM
07:21AM
05:30AM
02:13AM
Nov-29-23 06:04PM
05:45PM
05:18PM
09:00AM
05:00AM
Nov-28-23 01:34PM
01:34PM
06:30AM
05:41AM
Nov-27-23 09:56AM
06:03AM
05:30AM
Nov-26-23 07:15AM
06:51AM
06:30AM
05:56AM
Nov-25-23 04:22PM
Nov-24-23 08:20AM
03:49AM
12:07AM
Nov-23-23 05:11PM
Nov-22-23 01:01PM
05:06AM
Nov-21-23 03:20PM
12:41PM
11:53AM
08:32AM
Nov-20-23 01:25PM
12:02PM
07:15AM
06:52AM
05:56AM
05:04AM
Nov-19-23 02:05PM
Nov-17-23 09:21AM
06:03AM
Nov-16-23 06:30PM
12:13PM
11:30AM
07:30AM
05:50AM
Nov-15-23 04:31PM
11:57AM
10:07AM
09:57AM
09:00AM
Nov-14-23 05:30AM
Nov-13-23 04:05PM
02:14PM
06:02AM
Nov-11-23 05:00AM
Nov-10-23 07:48AM
07:38AM
Nov-09-23 05:21AM
04:06AM
Nov-08-23 02:53PM
09:45AM
Nov-07-23 09:21AM
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women's Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hait WilliamSee RemarksJul 26Option Exercise90.4414,6981,329,287102,445Jul 27 05:52 PM
Hait WilliamSee RemarksJul 26Sale172.0014,6982,528,05687,747Jul 27 05:52 PM
Fasolo PeterExec VP, Chief HR OfficerJul 25Sale170.3220,0003,406,498102,696Jul 27 05:52 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerJun 12Sale160.0012,4651,994,40065,934Jun 14 04:19 PM
Swanson James D.See RemarksMar 06Sale154.661,062164,1999,215Mar 08 04:16 PM
McEvoy AshleyEVP, WW Chair, MedTechFeb 10Option Exercise0.002,999044,812Feb 14 04:36 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 10Option Exercise0.003,5700130,026Feb 14 04:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 10Option Exercise0.005,2200300,940Feb 14 04:37 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 10Option Exercise0.002,0780116,754Feb 14 04:35 PM
Mongon ThibautExec VP, WW Chair, Cons HealthFeb 10Option Exercise0.002,285059,461Feb 14 04:35 PM
Hait WilliamSee RemarksFeb 10Option Exercise0.003,856084,092Feb 14 04:35 PM
Wolk Joseph JExec VP, CFOFeb 10Option Exercise0.003,449039,261Feb 14 04:36 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 10Option Exercise0.001,807073,118Feb 14 04:37 PM
Swanson James D.See RemarksFeb 10Option Exercise0.001,29108,355Feb 14 04:34 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 10Option Exercise0.001,592017,259Feb 14 04:35 PM
Decker Robert JVP Corporate ControllerFeb 10Option Exercise0.00581016,054Feb 14 04:35 PM
Gorsky AlexDirectorJan 17Option Exercise72.54547,69239,729,5781,133,194Jan 18 04:39 PM
Duato JoaquinCEO and Chairman of the BoardJan 17Option Exercise72.54148,53810,774,947394,515Jan 18 04:39 PM
Wolk Joseph JExec VP, CFODec 13Option Exercise88.1914,7811,303,58950,593Dec 15 04:34 PM
Wolk Joseph JExec VP, CFODec 13Sale179.6014,7812,654,66135,812Dec 15 04:34 PM